Abstract
Emergency departments (ED) across the world continue to grapple with the COVID-19 pandemic. One growing concern is the ability to rapidly diagnose those infected with the SARS-CoV-2 virus. While rapid assays have proven beneficial in such contexts as strep pharyngitis and influenza, it is unclear whether the recent rapid COVID-19 assays will prove beneficial to ED flow. The purpose of this study is to assess the effect of a rapid COVID-19 assay on patient flow through two academic emergency department sites.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
